Drug synthesis includes the synergistic action of enzyme 5 A-reductase inhibitor and antagonist of receptor a-epinephrine for the treatment of BPH.

摘要

Pharmaceutical composition comprising a synergistic combination of an inhibitor of the Enzyme 5 - reductase and an agent to - adrenergic receptor antagonist.Useful for treating benign prostatic hyperplasia.